Hearing results of intratympanic steroid treatment of endolymphatic hydrops

Laryngoscope

Volumn 108, Issue 11, 1998, Pages 1682-1685

  Arriaga, Moisés A ^a   Goldman, Steve ^b  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GELFOAM; HYALURONIC ACID; STEROID;

ARTICLE; CLINICAL ARTICLE; COCHLEA; EARDRUM; HEARING TEST; HUMAN; HYDROPS; INTRATYMPANIC DRUG ADMINISTRATION; MENIERE DISEASE; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME; TYMPANOPLASTY;

ADHESIONS; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; AUDIOMETRY, PURE-TONE; DEXAMETHASONE; ENDOLYMPHATIC HYDROPS; FOLLOW-UP STUDIES; GELATIN SPONGE, ABSORBABLE; GLUCOCORTICOIDS; HEARING; HEARING DISORDERS; HEMOSTATICS; HUMANS; HYALURONIC ACID; MENIERE'S DISEASE; RETROSPECTIVE STUDIES; ROUND WINDOW; SPEECH PERCEPTION; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 0031796662     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-199811000-00017     Document Type: Article

References (14)

1. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-90.
2. Derebery MJ, Rao VS, Siglock TJ, et al. Meniere’s disease: an immune complex-mediated illness? Laryngoscope 1991;101(3):225-9.
3. Pitovski DZ, Drescher MJ, Drescher DG. Glucocorticoid receptors in the mammalian inner ear: RV 28362 binding sites. Hear Res 1994;77:216-20.
4. Rarey RE, Lohuis PJ, Ten Cate WJ. Response of the stria vascularis to corticosteroids. Laryngoscope 1991;101:1081-4.
5. Sakata E, Itoh N, Itoh A, et al. Comparative studies of the therapeutic effect of inner ear anesthesia and middle ear anesthesia of a steroid solution for Meniere’s disease. Pract Otol (Kyoto) 1987;80:57-65.
6. Shea JJ, Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere’s disease. Otolaryngol Clin North Am 1996;29(2):353-8.
7. Silverstein H, Choo D, Rosenberg S, et al. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 1996;75(8):468-71.
8. Arriaga MA, Chen DA. Surgical management of uncompensated vestibular disease. Otolaryngol Clin North Am 1997;30(5):759-76.
9. Committee on Hearing and Equilibrium AAO-HNS. Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere’s disease. Otolaryngol Head Neck Surg 1995;113:181-5.
10. Shea JJ. The role of dexamethasone or streptomycin perfusion in the treatment of Meniere’s disease. Otolaryngol Clin North Am 1997;30(6):1051-9.
11. Silverstein H, Isaacson JE, Olds MJ, et al. Dexamethasone inner ear perfusion for the treatment of Meniere’s disease: a prospective, randomized, double-blind, crossover trial. Am J Otol 1998;19:196-201.
12. Silverstein H, Rowan PT, Olds MJ, et al. Inner ear perfusion and the role of round window patency. Am J Otol 1997;18(5):586-9.
13. Ikeda K. Morizono T. Effects of ototopic application of a corticosteroid preparation on cochlear function. Am J Otolaryngol 1991;12:150-3.
14. Morizono T, Paparella MM, Juhn SK. Ototoxicity of propylene glycol in experimental animals. Am J Otolaryngol 1980;1:393-9.